相关实验视频
Updated: May 6, 2026

12:31
In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
20.8K
对EFNB1基因c.451G>A(p.Gly151Ser) 突变的综合分析:通过in silico分析的结构,功能和致病性见解
Xiufang Yang1, Shangwen Shi1, Kai Fan2
1Department of Neonatology and PICU, Zhongshan City People's Hospital, NO.2 Sunwen Road, Zhongshan, Guangdong province, 528403, China.
Computers in biology and medicine
|August 15, 2025
概括
前鼻综合征 (CFNS) 与EFNB1基因突变有关. 一种新的变种 (p.Gly151Ser) 破坏了以弗林-B1蛋白的功能,影响了面发育和蛋白质相互作用.
科学领域:
- 遗传学和分子生物学
- 发展生物学 发展生物学
- 生物化学 生物化学
背景情况:
- 前鼻综合征 (CFNS) 是一种罕见的X相关性疾病.
- 编码ephrin-B1的EFNB1基因中的突变导致CFNS.
- 埃弗林-B1对面和神经发育至关重要.
研究的目的:
- 调查新型异构卵性EFNB1误解变异 (c.451G>A,p.Gly151Ser) 的影响.
- 使用in silico方法分析该变异对以弗林-B1蛋白功能的影响.
- 确定已识别的EFNB1突变的致病性.
主要方法:
- 整体外体序列测定用于在CFNS患者中识别EFNB1变异.
- 临床数据收集和儿童生长和神经发育的跟踪.
- 在分析包括AlphaFold3建模,HADDOCK对接和分子动力学模拟.
主要成果:
- 这种c.451G>A变体改变了蛋白质结构,增加了刚性并破坏了疏水性相互作用.
- 模拟显示了在二聚体界面上受损的EFNB1-EPHB2相互作用.
- 突变破坏了全球蛋白质结构的稳定性,同时调节了特定接口的结合动态.
结论:
- 这种c.451G>A变种具有潜在的致病性,有助于CFNS.
- 这项研究为EFNB1相关疾病的分子机制提供了洞察力.
- 进一步的研究是有必要的,以充分理解EFNB1相关条件.
相关概念视频
Mutations
66.9K
Overview
66.9K
Translation
133.8K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
133.8K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
160
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
160
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
84
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84

